advertisement

WGA Rescources

Abstract #90365 Published in IGR 21-3

Neuroprotection: A versatile approach to combat glaucoma

Naik S; Pandey A; Lewis SA; Rao BSS; Mutalik S
European Journal of Pharmacology 2020; 881: 173208


In most retinal diseases, neuronal loss is the main cause of vision loss. Neuroprotection is the alteration of neurons and/or their environment to encourage the survival and function of the neurons, especially in environments that are deleterious to the neuronal health. The area of neuroprotection progresses with a therapeutically-based hope of improving vision and clinical outcomes for patients through the developments in neurotrophic therapy, antioxidative therapy, anti-excitotoxic, anti-ischemic, anti-inflammatory, and anti-apoptotic care. In this review, we summarize the various neuroprotection strategies for the treatment of glaucoma, genetics of glaucoma and the role of various nanoplatforms in the treatment of glaucoma.

Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka State, India.

Full article

Classification:

11.8 Neuroprotection (Part of: 11 Medical treatment)



Issue 21-3

Change Issue


advertisement

Oculus